Recent Security Class Actions
Nabriva Therapeutics plc Ordinary Shares Ireland (NASDAQ: NBRV)
Company Name:Nabriva Therapeutics plc Ordinary Shares Ireland
Stock Symbol:NASDAQ: NBRV
Class Period Start:01/04/2019
Class Period End (inclusive):04/30/2019
Filing Deadline:07/08/2019
According to the Complaint, Nabriva Therapeutics plc is a biopharmaceutical company that purports to develop novel antiinfective agents to treat serious infections. One of the Company’s product candidates is CONTEPO, an epoxide antibiotic developed by Zavante Therapeutics (“Zavante”), which the Company acquired in July 2018.
